Skip to content
ANROAlto Neuroscience, Inc.

Earnings

When Alto Neuroscience, Inc. reports, what it reported each quarter, and how the stock took the results.

15 quarters. Mar 31, 2023 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Mar 15, after the close

Mon, Mar 15, 2027in 118 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 9 – 29

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$16.18M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$25.12MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 10, 2026, after the closeThe release+8.7%by the close of Nov 11
    Revenue
    —
    —
    Net income
    -$25.12M
    N/M
    EPS
    -$0.54
    N/M
  2. Q2 2026Aug 12, 2026, after the closeThe release+11.6%by the close of Aug 13
    Revenue
    —
    —
    Net income
    -$27.64M
    N/M
    EPS
    -$0.65
    N/M
  3. Q1 2026May 13, 2026, before the openThe release7.4%by the close of May 13
    Revenue
    —
    —
    Net income
    -$26.24M
    N/M
    EPS
    -$0.80
    N/M
  4. Q4 2025Mar 16, 2026, before the openThe release+8.2%by the close of Mar 16
    Revenue
    —
    —
    Net income
    -$16.18M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 10, 2026 · after-hoursNov 10, 202641 d10-Q——-$0.54+8.7%
Q2 2026Jun 30, 2026Aug 12, 2026 · after-hoursAug 12, 202643 d10-Q——-$0.65+11.6%
Q1 2026Mar 31, 2026May 13, 2026 · pre-marketMay 13, 202643 d10-Q——-$0.807.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 16, 2026 · pre-marketMar 16, 202675 d10-K———+8.2%
Q3 2025Sep 30, 2025Nov 12, 2025 · pre-marketNov 12, 202543 d10-Q——-$0.52+5.1%
Q2 2025Jun 30, 2025Aug 13, 2025 · after-hoursAug 13, 202544 d10-Q——-$0.65+0.3%
Q1 2025Mar 31, 2025May 14, 2025 · after-hoursMay 14, 202544 d10-Q——-$0.56+10.5%
FY 2024
Q4 2024derivedDec 31, 2024Mar 20, 2025 · after-hoursMar 20, 202579 d10-K———1.1%
Q3 2024Sep 30, 2024Nov 12, 2024 · after-hoursNov 12, 202443 d10-Q——-$0.62+1.1%
Q2 2024Jun 30, 2024Aug 13, 2024 · after-hoursAug 13, 202444 d10-Q——-$0.60+6.0%
Q1 2024Mar 31, 2024May 14, 2024 · after-hoursMay 14, 202444 d10-Q——-$0.765.2%
Earlier years, FY 2023 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 10, 2026000031
10-QAug 12, 2026000023
10-QMay 13, 2026000012
10-KMar 16, 2026000002
10-QNov 12, 2025000090
10-QAug 13, 2025000076
10-QMay 14, 2025000037
10-KMar 20, 2025000025
10-QNov 12, 2024000042
10-QAug 13, 2024000035

Provenance

ProvenanceData status and checks

Alto Neuroscience, Inc. · CIK 1999480 · Engraved from SEC EDGAR